Krebs Biochemicals (India) Price Prediction
| KREBSBIO | 106.58 3.16 2.88% |
Oversold Vs Overbought
47
Oversold | Overbought |
Quarterly Revenue Growth 0.218 |
Using Krebs Biochemicals hype-based prediction, you can estimate the value of Krebs Biochemicals and from the perspective of Krebs Biochemicals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Krebs Biochemicals to buy its stock at a price that has no basis in reality. In that case, they are not buying Krebs because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Krebs Biochemicals after-hype prediction price | INR 107.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Krebs |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Krebs Biochemicals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Krebs Biochemicals After-Hype Price Prediction Density Analysis
As far as predicting the price of Krebs Biochemicals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Krebs Biochemicals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Krebs Biochemicals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Krebs Biochemicals Estimiated After-Hype Price Volatility
In the context of predicting Krebs Biochemicals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Krebs Biochemicals' historical news coverage. Krebs Biochemicals' after-hype downside and upside margins for the prediction period are 102.58 and 111.72, respectively. We have considered Krebs Biochemicals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Krebs Biochemicals is very steady at this time. Analysis and calculation of next after-hype price of Krebs Biochemicals and is based on 3 months time horizon.
Krebs Biochemicals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Krebs Biochemicals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Krebs Biochemicals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Krebs Biochemicals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 4.57 | 0.57 | 4.61 | 1 Events / Month | 2 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
106.58 | 107.15 | 0.53 |
|
Krebs Biochemicals Hype Timeline
Krebs Biochemicals and is now traded for 106.58on National Stock Exchange of India of India. The entity has historical hype elasticity of 0.57, and average elasticity to hype of competition of -4.61. Krebs is forecasted to increase in value after the next headline, with the price projected to jump to 107.15 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.53%, whereas the daily expected return is now at 0.47%. The volatility of related hype on Krebs Biochemicals is about 46.56%, with the expected price after the next announcement by competition of 101.97. The company reported the revenue of 504.21 M. Net Loss for the year was (197.28 M) with profit before overhead, payroll, taxes, and interest of 244.19 M. Assuming the 90 days trading horizon the next forecasted press release will be very soon. Check out Krebs Biochemicals Basic Forecasting Models to cross-verify your projections.Krebs Biochemicals Related Hype Analysis
Having access to credible news sources related to Krebs Biochemicals' direct competition is more important than ever and may enhance your ability to predict Krebs Biochemicals' future price movements. Getting to know how Krebs Biochemicals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Krebs Biochemicals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APOLSINHOT | Apollo Sindoori Hotels | 0.00 | 2 per month | 1.87 | 0.06 | 6.25 | (3.55) | 24.10 | |
| ROUTE | ROUTE MOBILE LIMITED | (55.03) | 2 per month | 0.00 | (0.17) | 1.81 | (2.15) | 6.80 | |
| TAJGVK | Taj GVK Hotels | (1.80) | 2 per month | 1.79 | (0.01) | 4.51 | (3.12) | 11.81 | |
| RATNAMANI | Ratnamani Metals Tubes | 7.20 | 3 per month | 0.00 | (0.15) | 2.07 | (2.13) | 11.63 | |
| IITL | Industrial Investment Trust | 4.00 | 1 per month | 1.11 | 0.31 | 4.81 | (2.00) | 8.50 | |
| ONMOBILE | OnMobile Global Limited | (3.39) | 1 per month | 0.00 | (0.06) | 4.15 | (4.30) | 23.50 | |
| CHALET | Chalet Hotels Limited | (29.50) | 3 per month | 1.68 | 0 | 3.13 | (3.08) | 11.29 | |
| NAHARINDUS | Nahar Industrial Enterprises | 0.00 | 1 per month | 0.00 | (0.13) | 2.36 | (4.01) | 7.46 |
Krebs Biochemicals Additional Predictive Modules
Most predictive techniques to examine Krebs price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Krebs using various technical indicators. When you analyze Krebs charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Krebs Biochemicals Predictive Indicators
The successful prediction of Krebs Biochemicals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Krebs Biochemicals and, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Krebs Biochemicals based on analysis of Krebs Biochemicals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Krebs Biochemicals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Krebs Biochemicals's related companies.
Story Coverage note for Krebs Biochemicals
The number of cover stories for Krebs Biochemicals depends on current market conditions and Krebs Biochemicals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Krebs Biochemicals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Krebs Biochemicals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Krebs Biochemicals Short Properties
Krebs Biochemicals' future price predictability will typically decrease when Krebs Biochemicals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Krebs Biochemicals and often depends not only on the future outlook of the potential Krebs Biochemicals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Krebs Biochemicals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M | |
| Cash And Short Term Investments | 1.4 M |
Complementary Tools for Krebs Stock analysis
When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |